Integrating Cabozantinib in clinical practice when treating Neuroendocrine Tumor
Автор: OncUpdates: Latest Oncology Insights
Загружено: 2025-02-06
Просмотров: 552
Описание:
Dr. Vijayvergia discussed key findings from the CABINET trial comparing cabozantinib to placebo in patients with advanced GI neuroendocrine tumors. She further discussed the impact of these findings on the treatment landscape for patients with pancreatic and extra pancreatic neuroendocrine tumors, followed by how cabozantinib can be integrated into clinical practice, considering factors like tumor grade, functional status, and prior therapies.
Main Channel: / @oncologybrothers
Follow us on social media:
• X/Twitter: / oncbrothers
• Instagram: / oncbrothers
Don't forget to like, subscribe, and hit the notification bell for more updates on the latest in oncology research and practice!
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
